 The primary outcome of the study was to determine differences in glycemic control between treatment groups as measured by mean daily blood glucose concentration during the hospital stay. Secondary objectives were to determine differences in the percentage of glucose measures between 80 and 180 mgdl, frequency and severity of hypoglycemic events, total daily insulin use, length of hospital stay and glycemic viability between groups. 